Research programme: histamine H1 receptor antagonists - Almirall Prodesfarma
Alternative Names: LAS 36509; LAS 36674Latest Information Update: 22 Aug 2009
At a glance
- Originator Almirall-Prodesfarma
- Developer Almirall S.A
- Class
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Hypersensitivity
Most Recent Events
- 06 Apr 2004 Preclinical trials in Allergic rhinitis in Spain (unspecified route)
- 06 Apr 2004 Preclinical trials in Allergy in Spain (unspecified route)